As Bristol Myers Squibb Co (BMY) Market Valuation Declined, Holder Beech Hill Advisors Increased Its Position; Moneta Group Investment Advisors Stake in American Tower New Com (AMT) Has Upped as Share Value Rose

February 21, 2018 - By Louis Casey

Beech Hill Advisors Inc increased its stake in Bristol Myers Squibb Co (BMY) by 533.82% based on its latest 2017Q3 regulatory filing with the SEC. Beech Hill Advisors Inc bought 92,350 shares as the company’s stock declined 1.04% while stock markets rallied. The institutional investor held 109,650 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $6.99 million, up from 17,300 at the end of the previous reported quarter. Beech Hill Advisors Inc who had been investing in Bristol Myers Squibb Co for a number of months, seems to be bullish on the $109.95 billion market cap company. The stock decreased 2.33% or $1.61 during the last trading session, reaching $67.35. About 8.70 million shares traded or 20.30% up from the average. Bristol-Myers Squibb Company (NYSE:BMY) has declined 23.19% since February 21, 2017 and is downtrending. It has underperformed by 39.89% the S&P500.

Moneta Group Investment Advisors Llc increased its stake in American Tower Corp New Com (AMT) by 83.52% based on its latest 2017Q3 regulatory filing with the SEC. Moneta Group Investment Advisors Llc bought 3,132 shares as the company’s stock rose 18.69% with the market. The institutional investor held 6,882 shares of the real estate investment trusts company at the end of 2017Q3, valued at $941,000, up from 3,750 at the end of the previous reported quarter. Moneta Group Investment Advisors Llc who had been investing in American Tower Corp New Com for a number of months, seems to be bullish on the $59.71 billion market cap company. The stock decreased 0.56% or $0.78 during the last trading session, reaching $139.24. About 2.22 million shares traded. American Tower Corporation (NYSE:AMT) has risen 23.66% since February 21, 2017 and is uptrending. It has outperformed by 6.96% the S&P500.

Investors sentiment increased to 1.03 in 2017 Q3. Its up 0.08, from 0.95 in 2017Q2. It improved, as 62 investors sold BMY shares while 519 reduced holdings. 137 funds opened positions while 460 raised stakes. 1.11 billion shares or 0.68% more from 1.10 billion shares in 2017Q2 were reported. Natixis Asset Management holds 0.08% in Bristol-Myers Squibb Company (NYSE:BMY) or 15,211 shares. The Indiana-based Old National Bancorp In has invested 0.3% in Bristol-Myers Squibb Company (NYSE:BMY). Stevens First Principles Advisors has invested 0.16% in Bristol-Myers Squibb Company (NYSE:BMY). First Commercial Bank Of Mount Dora Inv, Florida-based fund reported 8,788 shares. Burney owns 21,664 shares. Muhlenkamp Inc holds 3.56% or 177,169 shares in its portfolio. Moreover, Natixis has 0.13% invested in Bristol-Myers Squibb Company (NYSE:BMY). Cape Cod Five Cents National Bank invested 0.26% in Bristol-Myers Squibb Company (NYSE:BMY). Keating Counselors stated it has 29,882 shares or 0.83% of all its holdings. 191,549 were reported by Canal Insur. Georgia-based Synovus Financial has invested 0.2% in Bristol-Myers Squibb Company (NYSE:BMY). Sector Pension Invest Board has invested 0.17% in Bristol-Myers Squibb Company (NYSE:BMY). Moreover, Loomis Sayles And LP has 1.89% invested in Bristol-Myers Squibb Company (NYSE:BMY) for 13.59M shares. Willis Counsel invested 0.82% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY). Roundview Limited owns 13,380 shares or 0.22% of their US portfolio.

Among 19 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 7 have Buy rating, 3 Sell and 9 Hold. Therefore 37% are positive. Bristol-Myers Squibb Company had 73 analyst reports since July 28, 2015 according to SRatingsIntel. Jefferies maintained it with “Hold” rating and $65 target in Tuesday, March 15 report. As per Monday, May 23, the company rating was initiated by Hilliard Lyons. The stock of Bristol-Myers Squibb Company (NYSE:BMY) earned “Outperform” rating by Credit Suisse on Monday, May 9. The stock of Bristol-Myers Squibb Company (NYSE:BMY) earned “Buy” rating by UBS on Friday, October 6. The rating was upgraded by SunTrust to “Buy” on Monday, October 30. The company was maintained on Thursday, October 19 by Cowen & Co. The firm has “Hold” rating given on Monday, October 16 by Jefferies. The firm has “Buy” rating given on Friday, January 22 by Berenberg. As per Thursday, November 16, the company rating was maintained by Jefferies. BMO Capital Markets maintained the stock with “Sell” rating in Sunday, July 23 report.

Since September 6, 2017, it had 1 buying transaction, and 2 selling transactions for $646,385 activity. Lynch Thomas J. Jr. also sold $335,172 worth of Bristol-Myers Squibb Company (NYSE:BMY) shares. $560,400 worth of stock was sold by Caldarella Joseph C on Wednesday, September 6.

Among 19 analysts covering American Tower Corporation (NYSE:AMT), 18 have Buy rating, 0 Sell and 1 Hold. Therefore 95% are positive. American Tower Corporation had 68 analyst reports since August 6, 2015 according to SRatingsIntel. The stock of American Tower Corporation (NYSE:REIT) has “Buy” rating given on Monday, August 28 by Citigroup. As per Monday, July 11, the company rating was maintained by Citigroup. The firm has “Buy” rating given on Tuesday, October 31 by SunTrust. As per Tuesday, July 4, the company rating was maintained by Stifel Nicolaus. The stock of American Tower Corporation (NYSE:REIT) has “Buy” rating given on Tuesday, April 11 by Guggenheim. Macquarie Research initiated the stock with “Outperform” rating in Tuesday, December 6 report. Argus Research maintained the stock with “Buy” rating in Wednesday, August 17 report. The firm earned “Buy” rating on Thursday, June 16 by Citigroup. On Monday, October 2 the stock rating was maintained by RBC Capital Markets with “Buy”. Jefferies maintained American Tower Corporation (NYSE:REIT) rating on Wednesday, November 1. Jefferies has “Buy” rating and $163 target.

Moneta Group Investment Advisors Llc, which manages about $13.82 billion and $643.44 million US Long portfolio, decreased its stake in Pentair Plc Shs (NYSE:PNR) by 19,140 shares to 3,275 shares, valued at $223,000 in 2017Q3, according to the filing. It also reduced its holding in Principal Finl Group Inc Com (NYSE:PFG) by 6,705 shares in the quarter, leaving it with 57,660 shares, and cut its stake in Masco Corp Com (NYSE:MAS).

Since August 24, 2017, it had 0 insider buys, and 7 sales for $18.32 million activity. Another trade for 10,000 shares valued at $1.38 million was made by DiSanto Edmund on Friday, September 22. $4.96M worth of American Tower Corporation (NYSE:REIT) shares were sold by TAICLET JAMES D JR. SHARBUTT DAVID E had sold 1,584 shares worth $228,793 on Wednesday, December 13. Another trade for 5,000 shares valued at $717,450 was sold by REEVE PAMELA D A.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>